RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19-Reference-Cited by-同舟云学术

RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19

Published:2021-04 Issue: Volume:103 Page:106330
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Ajmera Veeral,Thompson Wesley K.,Smith Davey M.,Malhotra Atul,Mehta Ravindra L.,Tolia Vaishal,Yin Jeffrey,Sriram Krishna,Insel Paul A.,Collier Summer,Richards Lisa,Loomba Rohit

Funder

NIDDK

Pfizer Healthcare Ireland

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference25 articles.

1. Remdesivir for the treatment of Covid-19 - preliminary report;Beigel;New England J. Med.,2020

2. Dexamethasone in hospitalized patients with Covid-19 - preliminary report;Horby;N. Engl. J. Med.,2020

3. Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results;Pan;N. Engl. J. Med.,2021

4. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention;Wu;Jama,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient;Inflammopharmacology;2024-04-15

2. Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses;Biomolecules;2023-09-26

3. Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial;Advances in Therapy;2023-08-24

4. ACEI or not to ACEI: Review on using ACEI and ARBs on COVID-19 patients: Systemic review;2023-03-29

5. Coronavirus disease 2019, hypertension, and renin–angiotensin–aldosterone system inhibitors;Current Opinion in Cardiology;2022-07-11